With strong flu season on horizon, Rite Aid urges flu shots
With the Centers for Disease Control and Prevention reporting widespread flu activity in 46 states, Rite Aid on Thursday urged people to get vaccinated against the flu if they haven’t already done so.
“With the CDC reporting widespread flu activity, health experts are predicting that the 2017-2018 flu season will be one of the worst in recent history,” stated Jocelyn Konrad, Rite Aid executive vice president of pharmacy.
[quote-from-article] “As we enter the peak of flu season, it’s not too late for people who haven’t been vaccinated against the flu to do so," she noted. "Though it takes two weeks to gain full protection against the flu, getting a flu shot as soon as possible is the single best way to fight the flu and the vaccine also helps to ease the severity and duration of symptoms if you come down with the flu.”
The CDC estimates the flu will infect 1-in-5 Americans this year.
With flu typically peaking between December and February, it’s possible for the flu season to run through March, meaning there is still time to get vaccinated.
FDA approves Lupin’s Tamiflu generic
The Food and Drug Administration has approved a generic of Hoffman-La Roche’s Tamiflu (oseltamivir phosphate) capsules from Lupin. The company’s generic will be available in 30-, 45- and 75-mg dosage strengths.
The product is inficated to treat acute, uncomplicated influenza A and B in patients 2 weeks of age and older, as well as to prevent influenza A and B in patients 1 year old and older. The drug had U.S. sales of roughly $467.8 million for the 12 months ended October 2017, according to IQVIA data.
Genoa marks telepsychiatry milestone
Behavioral health pharmacy and telepsychiatry company Genoa, a QoL Healthcare Company, has reached a big number with its remote psychiatry offering. The Tukwila, Wash.-based company announced Tuesday that it had facilitated more than 100,000 telepsych consultations on its video conferencing platform.
Genoa attributes the milestone to its recent buildup of its telepsychiatry operations, which grew to include 35 in 2017 from 20 at the start of the year, and included 250 providers. In 2017, the company grew to serve more than 2,500 patients per week.
“The need is clear. One-in-5 Americans has a mental illness, and one-in-17 has what is considered a serious and persistent mental illness such as schizophrenia, bipolar disorder or clinical depression. Getting care quickly can be a matter of life and death,” Genoa Telepsychiatry general manager Samir Malik said. “Unfortunately, more than 80 million Americans live in areas that do not have enough psychiatrists. This shortage contributes to nearly sixty percent of individuals who have an active mental illness failing to seek care.”
The company’s platform is able to reduce wait time for an appointment by as much as 30%, Genoa said, adding that it integrates workflows and reduces the need for extra communication among the care team.
“Eighty-five percent of our patients come back for follow-up visits. They really appreciate the service,” Malik said. “By empowering patients with greater choice in location and time, telepsychiatry helps tear down treatment barriers and reduce stigma – a key factor that keeps many from ever seeking care.”